Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$103.94 - $118.98 $708,766 - $811,324
6,819 New
6,819 $727,000
Q3 2021

Nov 15, 2021

SELL
$128.64 - $184.79 $5.23 Million - $7.52 Million
-40,688 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$160.2 - $186.42 $5.62 Million - $6.54 Million
35,088 Added 626.57%
40,688 $7.23 Million
Q1 2021

May 14, 2021

SELL
$150.19 - $173.5 $4.39 Million - $5.07 Million
-29,223 Reduced 83.92%
5,600 $920,000
Q4 2020

Feb 12, 2021

BUY
$140.71 - $165.05 $4.9 Million - $5.75 Million
34,823 New
34,823 $5.75 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.